Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02651610
Title Taxane Therapy With or Without Bavituximab for the Treatment of HER2-Negative Metastatic Breast Cancer
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors Peregrine Pharmaceuticals
Indications

Her2-receptor negative breast cancer

Therapies

Bavituximab

Paclitaxel

Age Groups: adult
Covered Countries USA


No variant requirements are available.